Showing results (21-30 of 131) with videos related to
Sort By:
Pageof 14
Infection and Drug Resistance|July 28, 2025
Successful Treatment of Lomentospora Prolificans Infection Following Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature ReviewYi-Han Yang, Chun Di, Hao Zheng, et al.Blood|October 23, 2016
Atorvastatin enhances endothelial cell function in posttransplant poor graft functionMin-Min Shi, Yuan Kong, Yang Song, et al.Cancers|April 26, 2025
Lack of Evidence Supporting a Significant Benefit of Pre-Transplant Consolidation Therapy in AML CR2 Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationMeng Lv, Ting Huang, Xiao-Dong Mo, et al.Transplant Immunology|March 27, 2023
Cytokine profiling during conditioning in haploidentical stem cell transplantation and its prognostic impact on early transplant outcomesNa Li, Chen Zhao, Rui Ma, et al.Clinical Transplantation|July 29, 2025
The Impact of Blast Percentage on Posttransplant Outcomes of Patients With Myelodysplastic Syndromes: A Retrospective Analysis Within the IPSS-M FrameworkZhong-Shi Lyu, Yu-Qian Sun, Xiao-Dong Mo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2020
Incidence, Risk Factors, and Outcomes of Primary Prolonged Isolated Thrombocytopenia after Haploidentical Hematopoietic Stem Cell TransplantFei-Fei Tang, Yu-Qian Sun, Xiao-Dong Mo, et al.Clinical Immunology (Orlando, Fla.)|April 27, 2026
The impact of pre-existing autoimmune diseases in myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective cohort studyNing Wu, Jing Liu, Meng Lv, et al.Bone Marrow Transplantation|July 17, 2025
Characteristics and prognosis of central nervous system relapse after allogeneic hematopoietic stem cell transplantation in adult patients with leukemiaLi-Ping Guo, Li-Juan Hu, Xiao-Dong Mo, et al.European Journal of Haematology|January 21, 2026
Bridging With Chimeric Antigen Receptor T-Cell Therapy or Chemotherapy to Allo-HSCT in B-ALL: A Comparison of Treatment Complications and SurvivalNing Wu, Jun Kong, Meng Lv, et al.The Journal of Infectious Diseases|January 20, 2025
Interleukin-6 is significantly increased in severe pneumonia after allo-HSCT and might induce lung injury via IL-6/sIL-6R/JAK1/STAT3 pathwayJing-Rui Zhou, Yi Liao, Le-Qing Cao, et al.Pageof 14